David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNH
1526
CNH Industrial
CNH
$18.7B
| $4.88M | 0.01% |
+549,638
| New | +$4.92M |
|
1527
CALL
Okta
OKTA
$23.4B
| $4.87M | 0.01% |
58,900
+30,000
| +104% | +$2.37M |
|
1528
Synaptics
SYNA
$3.74B
| $4.87M | 0.01% |
122,476
-165,620
| -57% | -$6.54M |
|
1529
Cheniere Energy
LNG
$58.7B
| $4.86M | 0.01% |
71,146
-86,436
| -55% | -$5.68M |
|
1530
PUT
Roku
ROKU
$23.5B
| $4.84M | 0.01% |
75,000
| – | – |
|
1531
Ovintiv
OVV
$17.8B
| $4.84M | 0.01% |
133,605
-34,417
| -20% | -$1.18M |
|
1532
Black Hills Corp
BKH
$5.63B
| $4.83M | 0.01% |
65,189
-47,298
| -42% | -$3.26M |
|
1533
CareDx
CDNA
$2.64B
| $4.83M | 0.01% |
153,179
-32,297
| -17% | -$941K |
|
|
EPAY
1534
DELISTED
Bottomline Technologies Inc
EPAY
| $4.8M | 0.01% |
95,755
+62,041
| +184% | +$3M |
|
1535
CALL
Carnival Corporation Ltd
CCL
$35B
| $4.79M | 0.01% |
94,500
+86,500
| +1,081% | +$4.79M |
|
1536
PUT
Newmont
NEM
$139B
| $4.79M | 0.01% |
133,900
-545,600
| -80% | -$18.5M |
|
1537
CALL
Realty Income
O
$58.9B
| $4.78M | 0.01% |
67,080
+30,960
| +86% | +$2.05M |
|
1538
Virtu Financial
VIRT
$5.8B
| $4.76M | 0.01% |
200,600
-153,008
| -43% | -$3.92M |
|
1539
Canadian Natural Resources
CNQ
$102B
| $4.74M | 0.01% |
352,410
-728,241
| -67% | -$9.68M |
|
1540
WSFS Financial
WSFS
$4.02B
| $4.72M | 0.01% |
+122,415
| New | +$5.09M |
|
1541
CALL
Skyworks Solutions
SWKS
$10B
| $4.72M | 0.01% |
57,200
+41,400
| +262% | +$3.2M |
|
1542
PUT
Bio-Rad Laboratories Class A
BIO
$10.4B
| $4.71M | 0.01% |
15,400
-13,000
| -46% | -$3.51M |
|
1543
PUT
Etsy
ETSY
$7.5B
| $4.71M | 0.01% |
70,000
+20,000
| +40% | +$1.19M |
|
|
GAP
1544
The Gap Inc
GAP
$7.61B
| $4.69M | 0.01% |
+179,129
| New | +$4.58M |
|
1545
Vericel Corp
VCEL
$2.17B
| $4.69M | 0.01% |
267,680
+159,041
| +146% | +$2.91M |
|
|
DNR
1546
DELISTED
Denbury Resources, Inc.
DNR
| $4.67M | 0.01% |
2,276,905
-4,294,114
| -65% | -$8.55M |
|
1547
CALL
Howmet Aerospace
HWM
$107B
| $4.66M | 0.01% |
317,785
+177,866
| +127% | +$2.55M |
|
|
JBTM
1548
JBT Marel
JBTM
$6.22B
| $4.66M | 0.01% |
50,676
+16,707
| +49% | +$1.41M |
|
|
TRTX
1549
TPG RE Finance Trust
TRTX
$592M
| $4.65M | 0.01% |
237,143
-28,638
| -11% | -$564K |
|
1550
Matthews International
MATW
$673M
| $4.63M | 0.01% |
125,339
-9,350
| -7% | -$381K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.